send link to app

Intercept 213 EU Study


4.6 ( 8736 ratings )
Medicina
Sviluppatore Snapiot Inc
Libero

This telemedicine app is intended to be used by patients enrolled in Intercepts 213 EU study. The purpose of this app is to connect patients and clinicians for the purpose of Intercepts study. Patients will use this app to schedule and conduct telemedicine calls.

This app is intended for users who are age 18 and over.